
Edward Loftus
@edwardloftus2
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.
ID: 776067721
http://mayoresearch.mayo.edu/mayo/research/staff/loftus_ev.cfm 23-08-2012 14:19:51
7,7K Tweet
13,13K Followers
2,2K Following

Highlighting our findings on RZB vs UST outcomes in bio-naive Crohn’s at Digestive Disease Week Parakkal Deepak MD, MS, FACG Edward Loftus Andres Yarur Jean-Frederic Colombel WashU Medicine Division of Gastroenterology WashU Medicine Inflammatory Bowel Disease Center

Very informative and happy #DDW2025 Digestive Disease Week with Mayo Clinic Gastroenterology & Hepatology friends! Edward Loftus Parakkal Deepak MD, MS, FACG See you at #DDW2026 in Chicago!!







Congratulations to Dr. Katie Katie Dunleavy on receiving the Barbara Bush Distinguished Fellowship Award, presented by GIH consultant Dr. Jean Fox! 🌟 Honoring her outstanding professional excellence and humanitarian values. #Leadership #GITwitter


Tuesday morning let’s do this Mayo Clinic Mayo Clinic Gastroenterology & Hepatology


Deucravacitinib in Patients With #IBD: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn’s Disease and Ulcerative Colitis academic.oup.com/ecco-jcc/artic… Remo Panaccione, MD, FRCPC Laurent Peyrin-Biroulet Y-ECCO Taku Kobayashi

Hearing Laura Raffals, MD talking about #IBD Plexus and SPARC at our Rochester Community Day Crohn's & Colitis Foundation - Minnesota/Dakotas Crohn's & Colitis Foundation Keep rocking it!



‘More options’ flood IBD market as rival IL-23 drugs face off with Stelara biosimilar boom Healio Gastroenterology healio.com/news/gastroent…

Edward Loftus Taku Kobayashi Remo Panaccione, MD, FRCPC Laurent Peyrin-Biroulet Y-ECCO Despite the putative MOA (IL-23 signal inhibition), it behaves more like IL-17 inhibitors: works for psoriasis and less effective than Pbo for #IBD. Quite interesting, worth looking into




Tauseef Ali MD, FACG AGAF FACP Yesenia Rojas-Khalil, MD,FACS Tracy Hull Alessandro Fichera Samuel Eisenstein Amy Lee Lightner, MD Stefan Holubar MD MS Maher A. Abbas, MD, FACS, FASCRS, FPSCRS-Honorary Phillip Fleshner MD Josh Tyler David M. Schwartzberg, MD Sonia Ramamoorthy, MD FACS FASCRS Karen Zaghiyan, M.D. Vincent Obias Eric Haas, MD Dr Feza Remzi Sean Langenfeld Andres Yarur Douglas G. Adler MD, FASGE, FACG, AGAF Anita Afzali MD, MPH, MHCM, FACG, AGAF Maria T. Abreu Waqqas Afif, MD Beatriz Gros Shrinivas Bishu Jonny Blackwell Badr Al-Bawardy Reezwana C, MD, FACG Edward Loftus Fernando Gomollón Neilanjan Nandi, MD, FACG, AGAF, FCCF, FACP Gursimran Kochhar MD Peter Higgins Shomron Ben-Horin Jalpa Devi Joseph Sleiman, MD, FACP 👩⚕️ Laura T 👩⚕️ There are obviously nuances, but in general: Anastomotic stricture: endo dilation; new acute SBO symptoms: Biologic; chronic SBO sympt, SBO refractory to meds, chronic stricture w proximal dilation: ✂️

